NCT06217003View on ClinicalTrials.gov

Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

February 1, 2025

Study Completion Date

August 1, 2025

Conditions
Osteosarcoma
Interventions
DRUG

Trilaciclib

Preoperative application of trilaciclib during perioperative chemotherapy

Trial Locations (1)

453100

The First Affiliated Hospital of Xinxiang Medical University, Xinxiang

All Listed Sponsors
lead

The First Affiliated Hospital of Xinxiang Medical College

OTHER

NCT06217003 - Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma | Biotech Hunter | Biotech Hunter